HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $87.40 billion. The enterprise value is $132.66 billion.
| Market Cap | 87.40B |
| Enterprise Value | 132.66B |
Important Dates
The last earnings date was Friday, April 25, 2025, before market open.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | Jun 16, 2025 |
Share Statistics
HCA Healthcare has 240.57 million shares outstanding. The number of shares has decreased by -5.86% in one year.
| Current Share Class | 240.57M |
| Shares Outstanding | 240.57M |
| Shares Change (YoY) | -5.86% |
| Shares Change (QoQ) | -2.30% |
| Owned by Insiders (%) | 1.38% |
| Owned by Institutions (%) | 68.16% |
| Float | 168.13M |
Valuation Ratios
The trailing PE ratio is 16.16 and the forward PE ratio is 13.92. HCA Healthcare's PEG ratio is 1.16.
| PE Ratio | 16.16 |
| Forward PE | 13.92 |
| PS Ratio | 1.29 |
| Forward PS | 1.15 |
| PB Ratio | -199.53 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 17.66 |
| P/OCF Ratio | 9.01 |
| PEG Ratio | 1.16 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.33, with an EV/FCF ratio of 26.81.
| EV / Earnings | 22.96 |
| EV / Sales | 1.85 |
| EV / EBITDA | 9.33 |
| EV / EBIT | 12.24 |
| EV / FCF | 26.81 |
Financial Position
The company has a current ratio of 1.19
| Current Ratio | 1.19 |
| Quick Ratio | 0.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.04 |
| Debt / FCF | 9.38 |
| Interest Coverage | 5.17 |
Financial Efficiency
Return on equity (ROE) is 1,605.77% and return on invested capital (ROIC) is 15.16%.
| Return on Equity (ROE) | 1,605.77% |
| Return on Assets (ROA) | 11.61% |
| Return on Invested Capital (ROIC) | 15.16% |
| Return on Capital Employed (ROCE) | 23.48% |
| Revenue Per Employee | $226,535 |
| Profits Per Employee | $18,288 |
| Employee Count | 316,000 |
| Asset Turnover | 1.23 |
| Inventory Turnover | 22.89 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.92 billion in taxes.
| Income Tax | 1.92B |
| Effective Tax Rate | 22.35% |
Stock Price Statistics
The stock price has increased by +11.21% in the last 52 weeks. The beta is 1.47, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.47 |
| 52-Week Price Change | +11.21% |
| 50-Day Moving Average | 335.46 |
| 200-Day Moving Average | 347.45 |
| Relative Strength Index (RSI) | 63.71 |
| Average Volume (20 Days) | 1,462,036 |
Short Selling Information
The latest short interest is 4.43 million, so 1.84% of the outstanding shares have been sold short.
| Short Interest | 4.43M |
| Short Previous Month | 5.58M |
| Short % of Shares Out | 1.84% |
| Short % of Float | 2.64% |
| Short Ratio (days to cover) | 2.54 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $71.59 billion and earned $5.78 billion in profits. Earnings per share was $22.47.
| Revenue | 71.59B |
| Gross Profit | 29.28B |
| Operating Income | 10.84B |
| Pretax Income | 7.57B |
| Net Income | 5.78B |
| EBITDA | 14.22B |
| EBIT | 10.84B |
| Earnings Per Share (EPS) | $22.47 |
Balance Sheet
The company has $1.17 billion in cash and $46.44 billion in debt, giving a net cash position of -$45.27 billion or -$188.17 per share.
| Cash & Cash Equivalents | 1.17B |
| Total Debt | 46.44B |
| Net Cash | -45.27B |
| Net Cash Per Share | -$188.17 |
| Equity (Book Value) | -438.00M |
| Book Value Per Share | -14.48 |
| Working Capital | 2.63B |
Cash Flow
In the last 12 months, operating cash flow was $9.70 billion and capital expenditures -$4.75 billion, giving a free cash flow of $4.95 billion.
| Operating Cash Flow | 9.70B |
| Capital Expenditures | -4.75B |
| Free Cash Flow | 4.95B |
| FCF Per Share | $20.57 |
Margins
Gross margin is 40.90%, with operating and profit margins of 15.15% and 8.07%.
| Gross Margin | 40.90% |
| Operating Margin | 15.15% |
| Pretax Margin | 12.02% |
| Profit Margin | 8.07% |
| EBITDA Margin | 19.86% |
| EBIT Margin | 15.15% |
| FCF Margin | 6.91% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 0.79%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 0.79% |
| Dividend Growth (YoY) | 9.52% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 12.82% |
| Buyback Yield | 5.86% |
| Shareholder Yield | 6.65% |
| Earnings Yield | 6.61% |
| FCF Yield | 5.66% |
Analyst Forecast
The average price target for HCA Healthcare is $375.67, which is 3.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $375.67 |
| Price Target Difference | 3.41% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (5Y) | 5.97% |
| EPS Growth Forecast (5Y) | 12.30% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.65 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.65 |
| Piotroski F-Score | 7 |